{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T14:21:27Z","timestamp":1786112487645,"version":"build-2736575974"},"reference-count":34,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,1]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n                  <jats:p>\n                    Vitiligo is a depigmentation skin disorder affecting 0.5%\u20131% of the inhabitants worldwide. Wtn signaling cascade is crucial in differentiation and development of melanocytes. Secreted frizzled-related protein 5 (SFRP5), member of the secreted frizzled-related proteins group, is well known as a suppressor of the Wnt signaling and represents a potential target of vitiligo. This study aimed to investigate immunohistochemical expression of SFRP5 in patients with nonsegmental vitiligo in comparison with healthy controls and to associate the results with the clinicopathologic information and included 48 participants: 24 patients with vitiligo and 24 healthy controls. All included participants were exposed to full history taking, full general and skin examination, scoring of vitiligo was done using vitiligo disease activity and vitiligo area scoring index scores. Immunohistochemical staining of SFRP5 was performed on punch biopsies from lesional, perilesional skin, and control skin. Comparison between lesional, perilesional, and control biopsies concerning epidermal SFRP5 expression revealed that SFRP5 staining, H score, and immunoreactivity scoring (IRS) were significantly elevated in all lesional and perilesional samples on comparison with controls (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). There were significant correlations regarding epidermal and dermal SFRP5 expression regarding percentage of positive cells, H-Score, and IRS (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    &lt; 0.001). Also, dermal SFRP5 was significantly associated with vitiligo disease activity score (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    = 0.051). SFRP5 being expressed in lesional and perilesional areas could have a potential role in pathogenesis of nonsegmental vitiligo and it can be a promising therapeutic target in the future. Also, SFRP5 has a prognostic role in these patients.\n                  <\/jats:p>","DOI":"10.1097\/dad.0000000000003148","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T18:00:18Z","timestamp":1759341618000},"page":"42-49","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Secreted Frizzled Related Protein 5 in Nonsegmental Vitiligo: A Clinical and Immunohistochemical Study"],"prefix":"10.1097","volume":"48","author":[{"given":"Wafaa Ahmed","family":"Shehata","sequence":"first","affiliation":[{"name":"Dermatology, Andrology & STDs Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed A.","family":"Shoeib","sequence":"additional","affiliation":[{"name":"Dermatology, Andrology & STDs Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eman Samy","family":"Mahmoud Abdou Flefal","sequence":"additional","affiliation":[{"name":"Health sector, Egypt; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmaa S.","family":"Mohamed","sequence":"additional","affiliation":[{"name":"Pathology Department, Faculty of Medicine, Menoufia University, Shebin El Kom, Egypt."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,10,1]]},"reference":[{"key":"R1-20260107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2016.10.048","article-title":"New discoveries in the pathogenesis and classification of vitiligo","volume":"77","author":"Rodrigues","year":"2017","journal-title":"J Am Acad Dermatol."},{"key":"R2-20260107","doi-asserted-by":"crossref","first-page":"711080","DOI":"10.3389\/fimmu.2021.711080","article-title":"Editorial: immunology of vitiligo","volume":"12","author":"Seneschal","year":"2021","journal-title":"Front Immunol."},{"key":"R3-20260107","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.3390\/cells12192387","article-title":"Using a topical formulation of vitamin D for the treatment of vitiligo: a systematic review","volume":"12","author":"Al-Smadi","year":"2023","journal-title":"Cells"},{"key":"R4-20260107","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.2147\/CCID.S319061","article-title":"Identification of the role of Wnt\/\u03b2-catenin pathway through integrated analyses and in vivo experiments in vitiligo","volume":"14","author":"Zhao","year":"2021","journal-title":"Clin Cosmet Investig Dermatol."},{"key":"R5-20260107","first-page":"1021","article-title":"Role of \u03b2-catenin in vitiligo: a clinical and immunohistochemical study","volume":"33","author":"Farag","year":"2020","journal-title":"Menoufia Med J."},{"key":"R6-20260107","doi-asserted-by":"crossref","first-page":"BSR20180011","DOI":"10.1042\/BSR20180011","article-title":"The Wnt antagonist and secreted frizzled-related protein 5: implications on lipid metabolism, inflammation, and type 2 diabetes mellitus","volume":"38","author":"Liu","year":"2018","journal-title":"Biosci Rep."},{"key":"R7-20260107","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1111\/j.1755-148X.2012.00997.x","article-title":"Revised classification\/nomenclature of vitiligo and related issues: the vitiligo Global issues Consensus Conference","volume":"25","author":"Ezzedine","year":"2012","journal-title":"Pigment Cell Melanoma Res."},{"key":"R8-20260107","doi-asserted-by":"crossref","first-page":"315","DOI":"10.4103\/0378-6323.26722","article-title":"Scoring systems in dermatology","volume":"72","author":"Bhor","year":"2006","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"R9-20260107","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaad.2015.06.033","article-title":"Skin biopsy: biopsy issues in specific diseases","volume":"74","author":"Elston","year":"2016","journal-title":"J Am Acad Dermatol."},{"key":"R10-20260107","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1097\/DAD.0000000000000539","article-title":"Clinicopathologic analysis of stable and unstable vitiligo: a study of 66 cases","volume":"38","author":"Yadav","year":"2016","journal-title":"Am J Dermatopathol"},{"key":"R11-20260107","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.lungcan.2013.07.016","article-title":"Evaluation of EGFR protein expression by immunohistochemistry using H-score and the magnification rule: re-analysis of the SATURN study","volume":"82","author":"Mazi\u00e8res","year":"2013","journal-title":"Lung Cancer"},{"key":"R12-20260107","first-page":"187","article-title":"Comparing of IRS and Her2 as immunohistochemical scoring schemes in gastroenteropancreatic neuroendocrine tumors","volume":"5","author":"Kaemmerer","year":"2012","journal-title":"Int J Clin Exp Pathol."},{"key":"R14-20260107","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1159\/000506103","article-title":"Vitiligo: a review","volume":"236","author":"Bergqvist","year":"2020","journal-title":"Dermatology"},{"key":"R15-20260107","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.abd.2021.09.008","article-title":"Update on the pathogenesis of vitiligo","volume":"97","author":"Marchioro","year":"2022","journal-title":"An Bras Dermatol."},{"key":"R16-20260107","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jdermsci.2017.06.018","article-title":"Precise role of dermal fibroblasts on melanocyte pigmentation","volume":"88","author":"Wang","year":"2017","journal-title":"J Dermatol Sci."},{"key":"R17-20260107","first-page":"8058","article-title":"Microphthalmia-associated transcription factor as a regulator for melanocyte-specific transcription of the human tyrosinase gene","volume":"14","author":"Yasumoto","year":"1994","journal-title":"Mol Cell Biol."},{"key":"R18-20260107","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1101\/gad.14.14.1712","article-title":"MITF from neural crest to melanoma: signal transduction and transcription in the melanocyte lineage","volume":"14","author":"Goding","year":"2000","journal-title":"Genes Dev."},{"key":"R19-20260107","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1083\/jcb.200202049","article-title":"Beta-catenin-induced melanoma growth requires the downstream target Microphthalmia-associated transcription factor","volume":"158","author":"Widlund","year":"2002","journal-title":"J Cell Biol."},{"key":"R20-20260107","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.devcel.2009.06.016","article-title":"Wnt\/beta-catenin signaling: components, mechanisms, and diseases","volume":"17","author":"MacDonald","year":"2009","journal-title":"Dev Cell"},{"key":"R21-20260107","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.jdermsci.2013.08.006","article-title":"Neural stem cells inhibit melanin production by activation of Wnt inhibitors","volume":"72","author":"Hwang","year":"2013","journal-title":"J Dermatol Sci."},{"key":"R22-20260107","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00403-024-03265-w","article-title":"Changes in epidermal thickness and their correlation with clinical characteristics in patients with vitiligo","volume":"316","author":"Huang","year":"2024","journal-title":"Arch Dermatol Res."},{"key":"R23-20260107","doi-asserted-by":"crossref","first-page":"1176781","DOI":"10.3389\/fmed.2023.1176781","article-title":"Melanocyte-keratinocyte cross-talk in vitiligo","volume":"10","author":"Touni","year":"2023","journal-title":"Front Med (Lausanne)"},{"key":"R24-20260107","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/01913123.2022.2044946","article-title":"Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis","volume":"46","author":"Elsherif","year":"2022","journal-title":"Ultrastruct Pathol."},{"key":"R25-20260107","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.gendis.2020.06.003","article-title":"SFRP5 inhibits melanin synthesis of melanocytes in vitiligo by suppressing the Wnt\/\u03b2-catenin signaling","volume":"8","author":"Zou","year":"2021","journal-title":"Genes Dis."},{"key":"R26-20260107","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1242\/jcs.026096","article-title":"Beyond Wnt inhibition: new functions of secreted Frizzled-related proteins in development and disease","volume":"121","author":"Bovolenta","year":"2008","journal-title":"J Cell Sci"},{"key":"R27-20260107","doi-asserted-by":"crossref","first-page":"5420","DOI":"10.3390\/cimb46060324","article-title":"Small peptide derived from SFRP5 suppresses melanogenesis by inhibiting Wnt activity","volume":"46","author":"Choi","year":"2024","journal-title":"Curr Issues Mol Biol."},{"key":"R28-20260107","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1111\/jdv.19022","article-title":"The possible role of Wnt\/\u03b2-catenin signalling in vitiligo treatment","volume":"37","author":"Lin","year":"2023","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"R29-20260107","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/j.celrep.2019.07.023","article-title":"SFRPs are biphasic modulators of Wnt-signaling-elicited cancer stem cell properties beyond extracellular control","volume":"28","author":"Liang","year":"2019","journal-title":"Cell Rep."},{"key":"R30-20260107","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s43088-024-00549-y","article-title":"Clinical study of Wnt inhibitory factor-1 expression and its association with disease severity in non-segmental vitiligo","volume":"13","author":"Gohary","year":"2024","journal-title":"Beni-Suef Univ J Basic Appl Sci."},{"key":"R31-20260107","first-page":"849","article-title":"Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis","volume":"24","author":"Moretti","year":"2009","journal-title":"Histol Histopathol."},{"key":"R32-20260107","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0378-6323.90942","article-title":"Melanocytorrhagy and apoptosis in vitiligo: connecting jigsaw pieces","volume":"78","author":"Kumar","year":"2012","journal-title":"Indian J Dermatol Venereol Leprol."},{"key":"R33-20260107","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1038\/jid.2015.335","article-title":"Transcriptional analysis of vitiligo skin reveals the alteration of WNT pathway: a promising target for repigmenting vitiligo patients","volume":"135","author":"Regazzetti","year":"2015","journal-title":"J Invest Dermatol."},{"key":"R34-20260107","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1038\/ncomms1734","article-title":"Activation of canonical Wnt signalling is required for TGF-\u03b2-mediated fibrosis","volume":"3","author":"Akhmetshina","year":"2012","journal-title":"Nat Commun."},{"key":"R35-20260107","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.jid.2017.06.033","article-title":"Vitiligo skin: exploring the dermal compartment","volume":"138","author":"Kovacs","year":"2018","journal-title":"J Invest Dermatol."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003148","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:06:29Z","timestamp":1785942389000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/DAD.0000000000003148"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000003148","relation":{},"ISSN":["0193-1091","1533-0311"],"issn-type":[{"value":"0193-1091","type":"print"},{"value":"1533-0311","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,1]]}}}